Category: pharma & healthcare

CAR T therapy has yet to be translated for T cell derived leukemias. One study leaves room for hope, as their CAR T product demonstrates early proof-of-concept.

Identifying those at risk of age-related macular degeneration is challenging but new technologies like artificial intelligence pave the way for more accurate diagnosis.

DARPins hold great promise for improving outcomes for patients with wet age-related macular degeneration and related conditions.

DARPins hold great promise for improving outcomes for patients with wet age-related macular degeneration and related conditions.

A new nasally administered Covid-19 vaccine shows greater promise in protecting patients from both Omicron infection and disease progression than traditional vaccines.

Despite the prevalence of dry eye disease it remains a mystery as to what exactly causes this condition. However, recent research has made strides in understanding it.

Cancer drug shortages aren’t new. Nor are the proposed solutions. But the critical nature of the public health emergency may serve as a call to federal government action.

Recent analyses show that the Omicron variants of SARS-CoV-2 more strongly suppress important immune markers than previous versions of the virus.

Induced pluripotent stem cells (iPSC), a continuing muse in cell therapy research, could potentially be used to improve flaws associated with conventional CAR T therapy.

Because Narcan isn’t typically used in instances of septic shock, the public is left with more questions than answers regarding its alleged use in Madonna’s case.